{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:21:09Z","timestamp":1770517269577,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"DOI":"10.7759\/cureus.103126","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:10:32Z","timestamp":1770433832000},"source":"Crossref","is-referenced-by-count":0,"title":["Neonatal Diabetes Mellitus Due to Homozygous ZNF808 Mutation Associated With Skeletal Anomalies: A Novel Presentation of Pancreatic Agenesis-3"],"prefix":"10.7759","author":[{"given":"Ali S","family":"Alquraishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musa M","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Rayees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1145","article-title":"Diabetes presentation in infancy: high risk of diabetic ketoacidosis","volume":"40","author":"Letourneau LR","year":"2017","unstructured":"Letourneau LR, Carmody D, Wroblewski K, et al.. Diabetes presentation in infancy: high risk of diabetic ketoacidosis. Diabetes Care. 2017, 40:e147-8. 10.2337\/dc17-1145","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000353538","article-title":"Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options","volume":"80","author":"Rubio-Cabezas O","year":"2013","unstructured":"Rubio-Cabezas O, Ellard S. Diabetes mellitus in neonates and infants: genetic heterogeneity, clinical approach to diagnosis, and therapeutic options. Horm Res Paediatr. 2013, 80:137-46. 10.1159\/000353538","journal-title":"Horm Res Paediatr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01565-x","article-title":"Primate-specific ZNF808 is essential for pancreatic development in humans","volume":"55","author":"De Franco E","year":"2023","unstructured":"De Franco E, Owens ND, Montaser H, et al.. Primate-specific ZNF808 is essential for pancreatic development in humans. Nat Genet. 2023, 55:2075-81. 10.1038\/s41588-023-01565-x","journal-title":"Nat Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome","volume":"25","author":"Del\u00e9pine M","year":"2000","unstructured":"Del\u00e9pine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000, 25:406-9. 10.1038\/78085","journal-title":"Nat Genet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15100","article-title":"Successful treatment of a cohort of infants with neonatal diabetes using insulin pumps including data on genetics and estimated incidence","volume":"109","author":"Torbj\u00f6rnsdotter T","year":"2020","unstructured":"Torbj\u00f6rnsdotter T, Marosvari-Barna E, Henckel E, Corrias M, Norgren S, Janson A. Successful treatment of a cohort of infants with neonatal diabetes using insulin pumps including data on genetics and estimated incidence. Acta Paediatr. 2020, 109:1131-7. 10.1111\/apa.15100","journal-title":"Acta Paediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0351-y","article-title":"New insights into K(ATP) channel gene mutations and neonatal diabetes mellitus","volume":"16","author":"Pipatpolkai T","year":"2020","unstructured":"Pipatpolkai T, Usher S, Stansfeld PJ, Ashcroft FM. New insights into K(ATP) channel gene mutations and neonatal diabetes mellitus. Nat Rev Endocrinol. 2020, 16:378-93. 10.1038\/s41574-020-0351-y","journal-title":"Nat Rev Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson ER","year":"2006","unstructured":"Pearson ER, Flechtner I, Nj\u00f8lstad PR, et al.. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006, 355:467-77. 10.1056\/NEJMoa061759","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.03.004","article-title":"Sulfonylurea-responsive diabetes in childhood","volume":"150","author":"Landau Z","year":"2007","unstructured":"Landau Z, Wainstein J, Hanukoglu A, Tuval M, Lavie J, Glaser B. Sulfonylurea-responsive diabetes in childhood. J Pediatr. 2007, 150:553-5. 10.1016\/j.jpeds.2007.03.004","journal-title":"J Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2494","article-title":"Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons","volume":"99","author":"Carmody D","year":"2014","unstructured":"Carmody D, Bell CD, Hwang JL, et al.. Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab. 2014, 99:E2709-14. 10.1210\/jc.2014-2494","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3921-8","article-title":"Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes","volume":"59","author":"Babiker T","year":"2016","unstructured":"Babiker T, Vedovato N, Patel K, et al.. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes. Diabetologia. 2016, 59:1162-6. 10.1007\/s00125-016-3921-8","journal-title":"Diabetologia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/456207-neonatal-diabetes-mellitus-due-to-homozygous-znf808-mutation-associated-with-skeletal-anomalies-a-novel-presentation-of-pancreatic-agenesis-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:10:36Z","timestamp":1770433836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/456207-neonatal-diabetes-mellitus-due-to-homozygous-znf808-mutation-associated-with-skeletal-anomalies-a-novel-presentation-of-pancreatic-agenesis-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.103126","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,6]]}}}